The purpose of this research study is to learn more about the risk of severe and fatal infusion-related reactions (IRR) in patients with multiple myeloma who are treated with their first 3 administrations of daratumumab. Examples of severe IRR include lung tightness, low oxygen levels, difficulty breathing, high blood pressure, racing heart, headache, and too much fluid in the lungs. No fatal IRRs have been observed in clinical trials of daratumumab. We are also doing this study to help us to identify potential risk factors for IRR.

The purpose of this study is to identify why households waste food. Using these causes of household food waste, we will work with participants to develop a comprehensive packet of tools that can be implemented in their daily lives to prevent food waste.

We are conducting a study to ask young adults with cervical cancer what information they think would be useful to include in a skill-building program to help navigate the financial aspects of cancer treatment. We will interview young adults with cervical cancer to learn about what is important to them and then ask for feedback on versions of the program as we develop it.

Have you ever wondered what environmental toxins you are exposed to on a daily basis, and how it might affect your health? The STRIVE study is looking for volunteers who would like to provide blood, urine, and/or saliva, as well as home samples such as soil, dust, and/or water. In this study, we want to learn more about the environmental factors that contribute to advanced liver disease and liver cancer. We are looking for healthy volunteers and people with liver cirrhosis who live in either North Carolina or Georgia to take part.

Do you have Non-Small Cell Lung Cancer? Have you previously been treated with Osimertinib? If so, you may be eligible for a trial comparing osimertinib in combination with other medications to treat your lung cancer. Please reach out if you're interested!

Have you been diagnosed with early stage triple negative breast cancer? We are asking you to take part in this research study because you have been diagnosed with triple-negative breast cancer (TNBC) and have recently completed preoperative chemotherapy in combination with pembrolizumab, followed by breast surgery. The chemotherapy plus pembrolizumab produced a pathologic complete response (pCR), meaning that no remaining cancer was found during your breast surgery.

In this project, we want to learn more about transgender and nonbinary individuals' sexual satisfaction. Sexual satisfaction is a prominent indicator of an individual's well-being and satisfaction with life. Current research focuses mainly on cisgender heterosexual populations. By focusing on people who identify under the nonbinary umbrella, in addition to binary-identifying trans people, we hope to examine how gender, the sociopolitical world, and a person's sexual satisfaction all intersect.

Finding new drugs is a long, expensive process. Drug repurposing, using an old drug for a new disorder, can make this process shorter and cheaper, and can occur by chance when a patient has two medical conditions that are treatable by the same drug. We hope that including you, the consumer, as a partner in drug development through self-report of unexpected benefits from medicinal agents could identify some with potential for repurposing. Your responses to a short Social Media survey may help you and others in the future.

Have you been diagnosed with breast cancer? If so, you may be able to take part in a research study for the collection of tumor specimens and genomic DNA from patients with early or metastatic breast cancer.

In this study, we want to learn more about the differences in dialects of Spanish. We will ask you some questions about different scenarios to help us understand more about language choice. En este trabajo, queremos aprender más sobre los diferencias dialectales en español. Vamos a preguntarte algunas preguntas sobre situaciones diferentes para ayudarnos entender más sobre el elección de lengua.